Steroids Flashcards
Cortisol
Class: Glucocorticoid
Mech: Binds GR, which regulates expression of genes with many effects on carbohydrate metabolism and immune function
Important SE’s: Cushing’s; glucocorticoid-induced osteoporosis; iatrogenic adrenal insufficiency
Misc: RelAnti-Inflam: 1; RelMin: 1; DoA: 8-12 hours
Cortisone acetate (Cortone): difference with cortisol:
Misc: RelAnti-Inflam: 0.8; RelMin: 0.8; DoA: 8-12 hours
Hydrocortisone: difference with cortisol:
Thera: Chronic primary adrenal insufficiency (maintenance); CAH
Misc: RelAnti-Inflam: 1; RelMin: 1; DoA: 8-12 hours
Prednisone (Deltasone): difference with cortisol:
Thera: CAH
Misc: RelAnti-Inflam: 4; RelMin: 0.8; DoA: 12-36 hours; 1/4 dose of cortisol
Prednisolone (Orapred): difference with cortisol:
Misc: RelAnti-Inflam: 4; RelMin: 0.8; DoA: 12-36 hours; 1/4 dose of cortisol
Methylprednisolone (Medrol): difference with cortisol:
Misc: RelAnti-Inflam: 5; RelMin: 0.5; DoA: 12-36 hours; 1/5 dose of cortisol
Triamcinolone: difference with cortisol:
Misc: RelAnti-Inflam: 5; RelMin: 0; DoA: 12-36 hours; 1/5 dose of cortisol
Dexamethasone (Decadron): difference with cortisol:
Thera: Emergency treatment (severe adrenal crisis, PAI); suppression test (Cushing’s); CAH
Misc: RelAnti-Inflam: 30; RelMin: 0; DoA: 8-12 hours; <1/20 dose of cortisol
Fludrocortisone
Class: Mineralocorticoid
Mech: Binds aldosterone receptor (AR) which increases Na+K+ATPase expression and increase epithelial sodium channel experession
Thera: Chronic primary adrenal insufficiency (maintenance); CAH
Important SE’s: Primary aldosteronism
Misc: RelAnti-Inflam: 10; RelMin: 125; DoA: 12-36 hours; very small dose
Aminoglutethide (Cytadren)
Mech: Blocks conversion of cholesterol to pregnenolone
Thera: Cushing’s Syndrome
Ketoconazole (Nizoral)
Class: Anti-fungal imidazole derivitive
Mech: Potent, nonselective inhibitor of adrenal and gonadal steroid synthesis
Thera: Cushing’s Syndrome
Mitotane (Lysodren)
Class: DDT insecticide relative
Mech: Nonselective cytotoxic action on adrenal cortex
Thera: Cushing’s Syndrome
Important SE’s: Bad side effect profile
Metyrapone (Metopirone)
Mech: Relatively selective inhibitor of 11-hydroxylation (interferes with cortisol and corticosterone synthesis)
Thera: Cushing’s syndrome; can use diagnostically to test anterior pituitary;
Misc: ACTH levels should rise in compensatory response to decreased cortisol and corticosterone, with precursor 11-deoxycortisol increasing also during metyrapone test
Mifepristone (RU-486)
Mech: Progesterone receptor antagonist; GR antagonist at high concentrations
Thera: Cushing’s syndrome (controls hyperglycemia secondary to hypercortisolism in those with endogenous Cushing’s syndrome who had issues with surgery); cortisol-induced psychosis
Important SE’s: Fatigue, nausea, headache, hypokalemia (moderate to severe since now crtisole can overwhelm the mineralocorticoid system), arthralgias
Other SE’s: edema and endometrial thickening in women;
Adrenal insufficiency that needs to be treated with withdrawal of mifepristone and then high-dose dexamethasone
Pasireotide
Class: somatostatin analog
Mech: Binds to somatostatin receptorand blocks release of ACTH from corticotropes
Thera: Cushing’s disease (pituitary)
Important SE’s: Hyperglycemia, GI problems
Spironolactone (Aldactone)
Mech: Aldosterone receptor antagonist
Thera: Primary aldosteronism
Important SE’s; Anti-androgenic
Eplerenone (Inspra)
Mech: Aldosterone receptor antagonist
Thera: Primary aldosteronism
Misc: More specific; less anti-androgenic effect than spironolactone
Glucocorticoids bind to _____, which proceeds to _____ and head into the ____ to activate _____
glucocorticoid receptor; dimerize; nucleus; GRE (glucocorticoid response element)